EBRT + Lu-PSMA for N1M0 Prostate Cancer

NCT05162573 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Prostatic Neoplasm

Interventions

DRUG: 177Lu-PSMA-617
RADIATION: EBRT

Sponsor

The Netherlands Cancer Institute

Collaborators

[object Object]
[object Object]